Generic User Fee Transition A Little Bumpy For Contract Manufacturers

Problems with self-identification process caused by timing of legislative renewal may have affected figures used by US FDA to calculate FY 2018 GDUFA fees.

US-Money-and-Pills_V2_1200x675

More from Generics

More from Biosimilars & Generics